StonvexLoading…
StonvexStonvexStonvexCore line items from OPRT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $19.46M | $22.67M | $25.57M | $31.19M |
Operating Income | $44.08M | $-115.18M | $-253.65M | $-75.29M |
Net Income | $25.25M | $-78.68M | $-179.95M | $-77.74M |
EPS (Diluted) | $0.53 | $-1.95 | $-4.88 | $-2.37 |
Total Assets | $3.26B | $3.23B | $3.41B | $3.61B |
Total Liabilities | $2.87B | $2.87B | $3.01B | $3.07B |
Cash & Equivalents | $105.53M | $59.97M | $91.19M | $98.82M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | $241.88M |
Shares Outstanding | 44.44M | 36.11M | 34.47M | 33.35M |